A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007827/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
24-week study to evaluate the efficacy and safety of macitentan for the treatment of
portopulmonary hypertension.
提供机构：
Vivli
创建时间：
2022-04-22
